Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features

被引:57
|
作者
Muniz-Castrillo, Sergio [1 ,2 ]
Joubert, Bastien [1 ,2 ]
Elsensohn, Mad-Helenie [3 ,4 ]
Pinto, Anne-Laurie [1 ,2 ]
Saint-Martin, Margaux [1 ,2 ]
Vogrig, Alberto [1 ,2 ]
Picard, Geraldine [1 ,2 ]
Rogemond, Veronique [1 ,2 ]
Dubois, Valerie [5 ]
Tamouza, Ryad [6 ,7 ]
Maucort-Boulch, Delphine [3 ,4 ]
Honnorat, Jerome [1 ,2 ]
机构
[1] Hosp Civils Lyon, Hop Neurol, French Natl Reference Ctr Paraneoplast Neurol Syn, Bron, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, SynatAc Team, INSERM,CNRS,Inst NeuroMyoGene,U1217,UMR 5310, Lyon, France
[3] Hosp Civils Lyon, Dept Biostat Bioinformat, Lyon, France
[4] Univ Claude Bernard Lyon 1, Univ Lyon, Lab Biometr & Evolutionary Biol, CNRS,UMR5558,Biostat Team, Villeurbanne, France
[5] EFS Auvergne Rhone Alpes, French Blood Serv, HLA Lab, Lyon, France
[6] Univ Paris Est Creteil, INSERM, U955, Mondor Inst Biomed Res, Creteil, France
[7] Hop Univ Henri Mondor, Dept Psychiat, Creteil, France
来源
关键词
CASPR2; HLA; limbic encephalitis; Morvan syndrome; neuromyotonia; CONTACTIN-ASSOCIATED PROTEIN-2; ANTI-LGI1; ENCEPHALITIS; LIMBIC ENCEPHALITIS; MORVANS-SYNDROME; ANTIBODIES; CASPR2;
D O I
10.1136/jnnp-2020-323226
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Antibodies against contactin-associated protein-like 2 (CASPR2-Abs) have been described in acquired neuromyotonia, limbic encephalitis (LE) and Morvan syndrome (MoS). However, it is unknown whether these constitute one sole spectrum of diseases with the same immunopathogenesis or three distinct entities with different mechanisms. Methods A cluster analysis of neurological symptoms was performed in a retrospective cohort of 56 CASPR2-Abs patients. In parallel, immunological features and human leucocyte antigen (HLA) were studied. Results Cluster analysis distinguished patients with predominant limbic symptoms (n=29/56) from those with peripheral nerve hyperexcitability (PNH; n=27/56). In the limbic-prominent group, limbic features were either isolated (LE/-; 18/56, 32.1%), or combined with extralimbic symptoms (LE/+; 11/56, 19.6%). Those with PNH were separated in one group with severe PNH and extralimbic involvement (PNH/+; 16/56, 28.6%), resembling historical MoS descriptions; and one group with milder and usually isolated PNH (PNH/-; 11/56, 19.6%). LE/- and LE/+ patients shared immunogenetic characteristics demonstrating a homogeneous entity. HLA-DRB1*11:01 was carried more frequently than in healthy controls only by patients with LE (94.1% vs 18.3%; p=1.3x10(-10)). Patients with LE also had serum titres (median 1:40 960) and rates of cerebrospinal fluid positivity (93.1%) higher than the other groups (p<0.05). Conversely, DRB1*11:01 association was absent in PNH/+ patients, but only they had malignant thymoma (87.5%), serum antibodies against leucine-rich glioma-inactivated 1 protein (66.7%) and against netrin-1 receptor deleted in colorectal carcinoma (53.8%), and myasthenia gravis (50.0%). Interpretation Symptoms' distribution supports specific clinical phenotypes without overlap between LE and MoS. The distinct immunogenetic characteristics shared by all patients with LE and the particular oncological and autoimmune associations of MoS suggest two very different aetiopathogenesis.
引用
收藏
页码:1076 / 1084
页数:9
相关论文
共 50 条
  • [21] Anti-CASPR2 Antibody-Associated Syndrome Presenting With Episodic Ataxia
    Lopes, Sofia
    Francisco, Leonor
    Moreira, Stefanie
    Varanda, Sara
    Araujo, Jose Manuel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [22] Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review
    Ghimire, Prinska
    Khanal, Ujjwal Prakash
    Gajurel, Bikram Prasad
    Karn, Ragesh
    Rajbhandari, Reema
    Paudel, Sunanda
    Gautam, Niraj
    Ojha, Rajeev
    BRAIN AND BEHAVIOR, 2020, 10 (10):
  • [23] Anti-CASPR2 Antibody-Associated Autoimmune Encephalitis Presenting as Refractory Seizures
    Balaji, Nivedha
    Ignatowicz, Aleksandra
    Kalra, Aarushi
    Mansour, Rami
    Jadhav, Vaishali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [24] Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis
    Joubert, Bastien
    Gobert, Florent
    Thomas, Laure
    Saint-Martin, Margaux
    Desestret, Virginie
    Convers, Philippe
    Rogemond, Veronique
    Picard, Geraldine
    Ducray, Francois
    Psimaras, Dimitri
    Antoine, Jean-Christophe
    Delattre, Jean-Yves
    Honnorat, Jerome
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (04):
  • [25] High prevalence of electrocardiac abnormalities in anti-CASPR2 antibody-associated disease
    Liu, Qing
    Ma, Jun
    Huang, Yan
    Ren, Hai Tao
    Lu, Qiang
    Zhang, Jun Yi
    Peng, Bin
    Guan, Yu Zhou
    Guan, Hong Zhi
    Cui, Li Ying
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (01): : 117 - +
  • [26] Anti-CASPR2 antibody associated encephalitis with anosmia and demyelinating pseudotumor: A case report
    Xing, Xiang
    Li, Jinmei
    Chen, Siliang
    Zheng, Linmao
    Feng, Wentao
    Liu, Yanhui
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 348
  • [27] Encephalopathy with upper body hypertonia and myoclonus in patient with systemic lupus erythematosus and anti-CASPR2
    Castro, A.
    Romeu, J. C.
    Geraldes, R.
    Pereira da Silva, J. A.
    LUPUS, 2017, 26 (01) : 84 - 87
  • [28] Successful Treatment of Anti-Caspr2 Syndrome by Interleulkin 6 Receptor Blockade Through Tocilizumab
    Krogias, Christos
    Hoepner, Robert
    Mueller, Andre
    Schneider-Gold, Christiane
    Schroeder, Alexandra
    Gold, Ralf
    JAMA NEUROLOGY, 2013, 70 (08) : 1056 - 1059
  • [29] Case report: Autoimmune encephalitis associated with anti-CASPR2 antibody mimicking cerebral infarction
    Chen, Ziqi
    Tang, Jing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report
    Vittorio Viti
    Gianni Cutillo
    Martina Rubin
    Chiara Zanetta
    Maria A. Rocca
    Massimo Filippi
    Journal of Neurology, 2025, 272 (5)